A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients

INTRODUCTION: Racial and ethnic minority groups have higher rates of SARS-CoV-2 infection, severe illness, and death; however, they receive monoclonal antibody (mAb) treatment at lower rates than non-Hispanic White patients. We report data from a systematic approach to improve equitable provision of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fish, Lindsey E., Bendelow, Tiffany, Gardiner, Sarah, Wynia, Matthew K., Kwan, Bethany M., Hamer, Mika K., Ginde, Adit A., Hanratty, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947608/
https://www.ncbi.nlm.nih.gov/pubmed/36845303
http://dx.doi.org/10.1017/cts.2022.526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947608/
https://www.ncbi.nlm.nih.gov/pubmed/36845303
http://dx.doi.org/10.1017/cts.2022.526

Ejemplares similares